ClinicalTrials.Veeva

Menu

Post Marketing Surveillance Study of Dysport

Ipsen logo

Ipsen

Status

Completed

Conditions

Cerebrovascular Accident
Cervical Dystonia
Equinus Deformity
Spasmodic Torticollis
Blepharospasm
Cerebral Palsy
Muscle Spasticity
Facial Hyperdynamic Lines
Hemifacial Spasm

Study type

Observational

Funder types

Industry

Identifiers

NCT00210431
Y-47-52120-093

Details and patient eligibility

About

The purpose of this study is to provide further information regarding the risks and benefits of Dysport in marketed indications.

Enrollment

783 patients

Sex

All

Ages

2+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult or child over the age of 2 years
  • scheduled to receive Dysport as per their normal treatment practice, and in conformance with their country's Summary of Product Characteristics

Exclusion criteria

  • history of hypersensitivity to Dysport or drugs with a similar chemical structure
  • treatment with any other investigational drug within the last 30 days before survey entry

Trial contacts and locations

36

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems